We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01470963
Previous Study | Return to List | Next Study

Practical Health Co-operation - The Impact of a Referral Template on Quality of Health Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01470963
Recruitment Status : Completed
First Posted : November 11, 2011
Last Update Posted : July 11, 2014
Sponsor:
Collaborator:
University of Tromso
Information provided by (Responsible Party):
University Hospital of North Norway

Brief Summary:

The purpose of this study is to examine whether the implementation of a referral template will increase quality of health care delivered and the quality of health care co-operation. The investigators intent to implement a referral template, at the level of the general practitioner (GP), for the referral of patients within 4 separate diagnostic groups:

  • dyspepsia/upper GI symptoms
  • colonic cancer investigation/lower GI symptoms
  • chronic obstructive pulmonary disease (COPD)
  • chest pain

Local GP clinics will be randomised to use the referral template or to use standard referral practice. Using a predefined set of quality criteria the investigators will score the process of care in each patient, and compare intervention and control groups. In addition other criteria will be collected and compared between the two groups, e.g.

  • time to diagnosis/treatment
  • quality of referral
  • more appropriate referrals
  • patient satisfaction (as measured by a questionnaire)

The investigators hypothesize that the implementation of a referral template will lead to a measurable increase in the quality of health care delivered.


Condition or disease Intervention/treatment Phase
Referral Quality of Health Care Other: Implementation of referral template Not Applicable

Detailed Description:

There is a continuous work to improve the quality of health care delivered to an individual patient, both in primary and secondary care. The referral from primary to secondary care represents a key component in the communication between the levels of care, and therefore an important tool in developing the quality of care. There has been many attempts at improving the quality of referrals, but less work has been focussed on the consequence of such improvement on quality of health care. This study is designed as a randomised controlled intervention study where we intent to implement a referral templates, at the level of the general practitioner (GP). These templates will be for the referral of patients within 4 separate diagnostic groups:

  • dyspepsia/upper GI symptoms
  • colonic cancer investigation/lower GI symptoms
  • chronic obstructive pulmonary disease (COPD)
  • chest pain

Following the course of the health care process we will assess the quality of the care process by using predefined quality of care criteria, together with patient satisfaction (as measured by questionnaire) and other health process indicators.

Our primary hypothesis is that the implementation of a referral template in the communication between primary and secondary care, will lead to a measurable increase in the quality of health care delivered.

Secondary hypothesis include:

  • the use of a referral template in the communication between the GP and secondary care, will lead to better patient satisfaction.
  • the use of a referral template in the communication between the GP and secondary care, will lead to a change (up or down) in the amount of patients defined as being in need of prioritisation (as defined pr. national guidelines for prioritisation in health care)
  • the use of a referral template in the communication between the GP and secondary care, will lead to a measurable referral quality improvement
  • the use of a referral template in the communication between the GP and secondary care, will increase the "appropriateness" of the referrals

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 500 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Practical Health Co-operation - a Randomised Controlled Intervention Study. The Impact of a Referral Template on Quality of Care and Health Care Co-operation Between Primary and Secondary Care
Study Start Date : September 2011
Actual Primary Completion Date : January 2014
Actual Study Completion Date : January 2014

Arm Intervention/treatment
Experimental: Referral template
Implementation of the referral templates at the GP office
Other: Implementation of referral template
Implementation of referral template at the GP office

No Intervention: Control
Normal referral pattern



Primary Outcome Measures :
  1. Collated quality indicator score [ Time Frame: The care period for each patient (approx. 3 weeks up to 1 year) ]
    Based on treatment guidelines and international quality assessment tools we have developed quality indicators score sets for each of the 4 diagnostic groups in the study. The scores will be compared between intervention and control GP offices to assess the effect of the referral template.


Secondary Outcome Measures :
  1. Improved referral quality [ Time Frame: The care period for each patient (approx. 3 weeks up to 1 year) ]
    The investigators will evaluate each referral against the referral template, and then compare between intervention and control groups.

  2. Waiting time from referral to appointment [ Time Frame: The care period for each patient (approx. 3 weeks up to 1 year) ]
  3. Time from referral to initiation of treatment [ Time Frame: The care period for each patient (approx. 3 weeks up to 1 year) ]
    Compare the time from referral to initiation of treatment/"decision no treatment" necessary between intervention and control groups

  4. Percentage of patients seen within investigation deadline [ Time Frame: Assessed at end of study - approx 2 years ]
    Compare the number of patients in the two groups seen within the limit set in national prioritisation guidelines

  5. Number of patients designated with investigation deadline [ Time Frame: Assessed at end of study - approx 2 years ]
    Compare the number of patients in the intervention vs. control group that were designated with a investigation deadline according to national prioritisation guidelines

  6. Patient satisfaction [ Time Frame: The care period for each patient (approx. 3 weeks up to 1 year) ]
    Patient satisfaction as measured by self report questionnaire

  7. Positive predictive value of referral [ Time Frame: The care period for each patient (approx. 3 weeks up to 1 year) ]

    Compare the percentage of referrals between the intervention and control groups which have lead to

    1. a diagnostic clarification, or
    2. a histological diagnosis, or
    3. a change in medical management

  8. Number of appointments needed for diagnostic clarification [ Time Frame: The care period for each patient (approx. 3 weeks up to 1 year) ]
    Compare the number of appointments needed to clarify diagnosis between intervention and control groups



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • referral to medical department of University Hospital of North Norway, Harstad

Exclusion Criteria:

  • children (< 18 years of age)
  • patients with reduced capacity to consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01470963


Locations
Layout table for location information
Norway
Medical department - University Hospital of North Norway Harstad
Harstad, Norway, 9480
Sponsors and Collaborators
University Hospital of North Norway
University of Tromso
Investigators
Layout table for investigator information
Principal Investigator: Ann Ragnhild Broderstad, Dr. med University Hospital of North Norway
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University Hospital of North Norway
ClinicalTrials.gov Identifier: NCT01470963    
Other Study ID Numbers: HST1026-11
First Posted: November 11, 2011    Key Record Dates
Last Update Posted: July 11, 2014
Last Verified: July 2014
Keywords provided by University Hospital of North Norway:
Referral
Quality of Health Care